TP53 and head and neck squamous cell carcinoma: This observation could help to explain why HNSCC patients with both TP53 mutations and high levels of FOXM1 expression had the poorest survival outcomes among those we studied (Fig. 7j), and this knowledge will help us not only understand the molecular pathogenesis of HNSCCs but also develop therapeutic strategies against them.